Radiographic sacroiliitis progression in axial spondyloarthritis: central reading of 5-year follow-up data from the ASAS cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/33537702/

Data-Driven Definitions for Active and Structural MRI Lesions in the Sacroiliac Joint in Spondyloarthritis and their Predictive Utility (2021)
https://pubmed.ncbi.nlm.nih.gov/33523107/

Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32710108/

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33317138/

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW (2020)
https://pubmed.ncbi.nlm.nih.gov/32371433/

IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32242816/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group (2019)
https://pubmed.ncbi.nlm.nih.gov/31422357/

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts (2019)
https://pubmed.ncbi.nlm.nih.gov/31362994/

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison (2019)
https://pubmed.ncbi.nlm.nih.gov/31174584/